Fennec Pharmaceuticals Inc. (TSX:FRX)

Fennec Pharmaceuticals Revenue

In the year 2024, Fennec Pharmaceuticals had annual revenue of $47.54M USD with 123.69% growth. Fennec Pharmaceuticals had revenue of $7.93M in the quarter ending December 31, 2024, a decrease of -18.59%.

• Revenue: $47.54M
• Revenue Growth: +123.69%
• P/S Ratio: 2.84
• Revenue / Employee: $1.49M
• Employees: 32
• Market Cap: 194.33M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	47.54M	26.29M	123.69%
Dec 31, 2023	21.25M	19.72M	1,284.50%
Dec 31, 2022	1.54M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	170.00K	-	-